Literature DB >> 26468224

Multifocal chorioretinitis with progressive subretinal fibrosis in a young child.

Laura R Steeples1, Jane Ashworth1, Nicholas Jones2.   

Abstract

Progressive subretinal fibrosis with uveitis (PSFU) syndrome is a rare clinical entity presenting with multifocal granulomatous chorioretinitis and subsequently developing extensive subretinal fibrosis over weeks or months. Subretinal fibrosis affecting the macula may cause profound and permanent vision loss. We report the presentation and management of this condition in a child, to our knowledge, the youngest reported. The condition caused substantial visual loss and required high-dose systemic corticosteroid and immunosuppression with methotrexate and ciclosporin to control aggressive intraocular inflammation. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26468224      PMCID: PMC4612310          DOI: 10.1136/bcr-2015-212526

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  [Multifocal choroiditis with subretinal fibrosis].

Authors:  S Onoda; K Shibuya; H Miyasaka; Y Kobayashi; J Pang; Y Kawashima
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1997-09

2.  Progressive subretinal fibrosis and multifocal granulomatous chorioretinitis.

Authors:  Miguel Hage Amaro; Cristina Muccioli; Mario Martins dos Santos Motta
Journal:  Arq Bras Oftalmol       Date:  2006 May-Jun       Impact factor: 0.872

3.  Punctate inner choroidopathy: a survey analysis of 77 persons.

Authors:  Adam T Gerstenblith; Jennifer E Thorne; Lucia Sobrin; Diana V Do; Syed Mahmood Shah; C Stephen Foster; Douglas A Jabs; Quan Dong Nguyen
Journal:  Ophthalmology       Date:  2007-04-16       Impact factor: 12.079

4.  Successful treatment with infliximab in a patient with Diffuse Subretinal Fibrosis syndrome.

Authors:  Alfredo Adán; Raimon Sanmartí; Anniken Burés; Ricardo P Casaroli-Marano
Journal:  Am J Ophthalmol       Date:  2006-11-28       Impact factor: 5.258

5.  Progressive subretinal fibrosis and uveitis.

Authors:  A G Palestine; R B Nussenblatt; L M Parver; D L Knox
Journal:  Br J Ophthalmol       Date:  1984-09       Impact factor: 4.638

6.  The Manchester Uveitis Clinic: the first 3000 patients--epidemiology and casemix.

Authors:  Nicholas P Jones
Journal:  Ocul Immunol Inflamm       Date:  2013-12-02       Impact factor: 3.070

7.  Multifocal choroiditis associated with progressive subretinal fibrosis.

Authors:  H L Cantrill; J C Folk
Journal:  Am J Ophthalmol       Date:  1986-02-15       Impact factor: 5.258

8.  Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome.

Authors:  J Brown; J C Folk; C V Reddy; A E Kimura
Journal:  Ophthalmology       Date:  1996-07       Impact factor: 12.079

9.  Immunopathology of progressive subretinal fibrosis: a variant of sympathetic ophthalmia.

Authors:  Wee-Kiak Lim; Soon-Phaik Chee; Ivy Sng; Robert Burton Nussenblatt; Chi-Chao Chan
Journal:  Am J Ophthalmol       Date:  2004-09       Impact factor: 5.258

10.  Treatment of diffuse subretinal fibrosis uveitis with rituximab.

Authors:  Kurt Spiteri Cornish; Lucia Kuffova; John V Forrester
Journal:  Br J Ophthalmol       Date:  2014-05-30       Impact factor: 4.638

  10 in total
  2 in total

Review 1.  Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.

Authors:  Ioannis Papasavvas; Ilknur Tugal-Tutkun; Carl P Herbort
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

2.  Clinical Features and Surgical Treatment of Subretinal Proliferation in Proliferative Diabetic Retinopathy.

Authors:  Chan Wu; Rongping Dai; Youxin Chen; Xiao Zhang; Zhe Chen
Journal:  Front Med (Lausanne)       Date:  2022-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.